Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase (vol 8, pg 762, 2020)

被引：1
|
作者：
Pivonello, R.
Fleseriu, M.
Newell-Price, J.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 09期
关键词：
D O I：
10.1016/S2213-8587(20)30275-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e4 / e4
页数：1
相关论文
共 50 条
  • [21] The efficacy and safety of keverprazan in treatment of duodenal ulcer: A phase III, randomized, double-blind, multicentre trial
    Tan, Niandi
    Miao, Xin-Pu
    Liao, Ai-Jun
    Liu, Cheng-Xia
    Wu, Hao
    Chen, Hong-Hui
    Li, Fang-Fang
    Guo, Qing-Hong
    Li, Sheng-Bao
    Tang, Yan-Ping
    Xia, Min
    Liu, You-Li
    Li, Xing
    Chen, Hui-Xin
    Liu, Xiao-Wei
    Zhang, Yan
    Zhang, Zhen-Yu
    Chen, Min-Hu
    Xiao, Ying-Lian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 38 - 39
  • [22] Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised double-blind, multicentre, placebo-controlled phase 3 trial
    Habib, Ali A.
    Zhao, Chongbo
    Aban, Inmaculada
    Franca Jr, Marcondes Cavalcante
    Jose, Jorge Gustavo
    Hoerste, Gerd Meyer zu
    Klimiec-Moskal, Elzbieta
    Pulley, Michael T.
    Tavolini, Dario
    Krumova, Petranka
    Lennon-Chrimes, Sian
    Smith, Jillian
    Thanei, Gian-Andrea
    Blondeau, Kathleen
    Vodopivec, Ivana
    Wolfe, Gil, I
    Murai, Hiroyuki
    LANCET NEUROLOGY, 2025, 24 (02) : 117 - 127
  • [23] Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (vol 21, pg 125, 2022)
    Mignot, E.
    Mayleben, D.
    Fietze, I
    LANCET NEUROLOGY, 2022, 21 (06) : E6 - E6
  • [24] Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
    Di Lorenzo, Carlo
    Khlevner, Julie
    Rodriguez-Araujo, Gerardo
    Xie, Wangang
    Huh, Susanna Y.
    Ando, Masakazu
    Hyams, Jeffrey S.
    Nurko, Samuel
    Benninga, Marc A.
    Simon, Michael
    Hewson, Marcella E.
    Saps, Miguel
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (03): : 238 - 250
  • [25] The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: A phase III, randomised, double-blind multicentre study
    Chen, Songfeng
    Liu, Deliang
    Chen, Honghui
    Liao, Aijun
    Li, Fangfang
    Liu, Chengxia
    Li, Xing
    Li, Shengbao
    Zhang, Yan
    Wang, Yang
    Xia, Min
    Guo, Qinghong
    Miao, Xinpu
    Wen, Zhili
    Xu, Min
    Yin, Hekun
    Chen, Huixin
    Chen, Minhu
    Xiao, Yinglian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (12) : 1524 - 1533
  • [26] Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial (vol 401, pg 1518, 2023)
    McInnes, Iain B.
    Merola, Joseph F.
    LANCET, 2023, 401 (10392) : 1928 - 1928
  • [27] Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (vol 21, pg 125, 2022)
    Mignot, E.
    Mayleben, D.
    Fietzeet, I
    LANCET NEUROLOGY, 2022, 21 (03)
  • [28] Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4)
    Shimatsu, Akira
    Biller, Beverly M. K.
    Fleseriu, Maria
    Pivonello, Rosario
    Lee, Eun Jig
    Leelawattana, Rattana
    Kim, Jung Hee
    Walia, Rama
    Yu, Yerong
    Liao, Zhihong
    Piacentini, Andrea
    Pedroncelli, Alberto M.
    Snyder, Peter J.
    ENDOCRINE JOURNAL, 2024, 71 (12) : 1103 - 1123
  • [29] Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
    Papp, K.
    Bissonnette, R.
    Rosoph, L.
    Wasel, N.
    Lynde, C. W.
    Searles, G.
    Shear, N. H.
    Huizinga, R. B.
    Maksymowych, W. P.
    LANCET, 2008, 371 (9621) : 1337 - 1342
  • [30] Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease
    Pivonello, R.
    Fleseriu, M.
    Newell-Price, J.
    Shimatsu, A.
    Feelders, R. A.
    Kadioglu, P.
    Tabarin, A.
    Brue, T. C.
    Geer, E. B.
    Piacentini, A.
    Pedroncelli, A. M.
    Biller, B. M. K.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (10) : 2437 - 2448
12345